Submit your research today!
Current Medical Research & Opinion Special Issue: Real-World Evidence & Medical Affairs
About this special issue
According to the FDA, real-world evidence (RWE) is “the clinical evidence regarding the usage and potential benefits or risks of a medical product derived from analysis of real-world data. Real-world data are the data relating to patient health status and/or the delivery of health care routinely collected from a variety of sources”. RWE can be generated by different study designs or analyses, including but not limited to, randomised trials, large simple trials, pragmatic trials, and observational studies (prospective and/or retrospective). Due to their ability to collect data on groups that are routinely excluded from randomised controlled trials, RWE studies have become recognised as a useful supplement during clinical development.
The wider context of RWE incorporates the discipline of medical affairs, which has been defined as the “medical speciality that protects patients’ interests by regulating pharmaceutical company activities and leads medicine adoption through the design, implementation and communication of real-world evidence targeted to the needs of regulators, payors, prescribers and patients”. The main purpose of medical affairs is to ensure that patients’ interests are safeguarded and not overshadowed by commercial need in the context of the pharmaceutical industry.
RWE exists within a specific context and has specific purposes for the multiple stakeholders involved in medicine adoption: regulators, payors, prescribers, and patients. However, RWE publications are currently dispersed throughout the body of knowledge, with no dedicated space where stakeholders can find the evidence they need for crucial decision-making. Additionally, since this is a time of great advancement in the generation and use of RWE during clinical development, there is a need for dedicated forums for engaging in academic debate
This special issue on Real-World Evidence & Medical Affairs in Current Medical Research & Opinion (Impact Factor; 2.705, Citescore 4.0), featuring Guest Editor, Ravi Jandhyala, provides a dedicated space for RWE findings and discussion, with the aim of ensuring that patients receive optimal treatments at the earliest opportunity. The issue will cover a wide range of perspectives from both key opinion leaders from academia and industry. Topics of interest include, but are not limited to:
How real-world studies are generated and regulated
Insights from various stakeholders involved in generating real-world data
Insights from various stakeholders involved in decision-making
Studies from across a wide range of therapy areas using RWE
Discussion on the unmet challenges and future potentials for RWE
The evolution and development of medical affairs as a discipline
The issue welcomes authors to submit relevant original research, reviews, editorials, commentaries, and research letters. The benefit of publishing as part of a special issue is that the articles included often receive more views and higher citation numbers.
If you are interested in submitting content or have any questions, please contact Mithi Ahmed-Richards, Executive Editor of Current Medical Research and Opinion. Learn more about preparing your manuscript by visiting the Instructions for Authors page.
Submission information
Submission Deadlines:
Standard track: 15th April 2023
Rapid track: 15th May 2023
Fast track: 15th June 2023
Accelerated Publication
Publish in 3 – 5 weeks from submission
Submission to acceptance: 2 – 3 weeks
1 – 2 weeks for peer review
1 week for author revision
Acceptance to online publication: 1 – 2 weeks, with proofs within 5 working days and 48 hours for author review
Cost per article: $7000 / €6200 / £5500
Publish in 7 – 9 weeks from submission
Submission to acceptance: 5 – 6 weeks
3 – 4 weeks for peer review
2 weeks for author revision
Acceptance to online publication: 2 – 3 weeks, with proofs within 10 working days
Cost per article: $3900 / €3400 / £3000
By publishing in Current Medical Research & Opinion you will:
Gain recognition from an international audience and increase your opportunities for future collaboration
Receive 50 free e-prints & promotional tips on promoting your article courtesy of our Author Services site
Immediately see the impact of your research made in the community by tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
Increase the discoverability of your research with MEDLINE listings and more